COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,015 Articles (22,627 medRxiv, 8,388 bioRxiv)

Most recent first Previous |  Page 913: Articles 9121-9130  | Next

The mechanism of RNA capping by SARS-CoV-2
Park, G. J., Osinski, A., Hernandez, G., Eitson, J., Majumdar, A., Tonelli, M., Henzler-Wildman, K., Pawlowski, K., Chen, Z., Li, Y., Schoggins, J., Tagliabracci, V. S.
10.1101/2022.02.07.479471 — Posted: 2022-02-09
The mechanisms of catalysis and ligand binding for the SARS-CoV-2 NSP3 macrodomain from neutron and X-ray diffraction at room temperature
Correy, G. J., Kneller, D. W., Phillips, G., Pant, S., Russi, S., Cohen, A. E., Meigs, G., Holton, J. M., Gahbauer, S., Thompson, M. C., Ashworth, A., Coates, L., Kovalevsky, A., Meilleur, F., Fraser, J. S.
10.1101/2022.02.07.479477 — Posted: 2022-02-09
Boosting with Omicron-matched or historical mRNA vaccines increases neutralizing antibody responses and protection against B.1.1.529 infection in mice
Ying, B., Scheaffer, S. M., Whitener, B., Liang, C.-Y., Dmytrenko, O., Mackin, S., Wu, K., Lee, D., Avena, L. E., Chong, Z., Case, J. B., Ma, L., Kim, T., Sein, C., Woods, A., Carfi, A., Elbashir, S. M., Edwards, D. K., Thackray, L. B., Diamond, M. S.
10.1101/2022.02.07.479419 — Posted: 2022-02-09
Antibody Evasion Properties of SARS-CoV-2 Omicron Sublineages
Iketani, S., Liu, L., Guo, Y., Liu, L., Huang, Y., Wang, M., Luo, Y., Yu, J., Yin, M. T., Sobieszczyk, M. E., Huang, Y., Wang, H. H., Sheng, Z., Ho, D. D.
10.1101/2022.02.07.479306 — Posted: 2022-02-09
Neutralization Of SARS-CoV-2 Variants By A Human Polyclonal Antibody Therapeutic (COVID-HIG, NP-028) With High Neutralizing Titers To SARS-CoV-2
Toth, D.
10.1101/2022.01.27.478053 — Posted: 2022-02-09
Distinct sensitivities to SARS-CoV-2 variants in vaccinated humans and mice
Walls, A. C., VanBlargan, L. A., Wu, K., Choi, A., Navarro, M. J., Lee, D., Avena, L., Berrueta, D. M., Pham, M. N., Elbashir, S., Miranda, M. C., Kepl, E., Johnson, M., Blackstone, A., Sprouse, K. R., Fiala, B., O'Connor, M. A., Brunette, N., S Arunachalam, P., Shirreff, L., Rogers, K. A., Carter, L., Fuller, D. H., Villinger, F. J., Pulendran, B., Diamond, M. S., Edwards, D. K., King, N. P., Veesler, D.
10.1101/2022.02.07.479468 — Posted: 2022-02-09
Bacterial Pneumonia and Respiratory Culture Utilization among Hospitalized Patients with and without COVID-19 in New York City
Weidmann, M. D., Berry, G. J., Zucker, J. E., Huang, S., Sobieszczyk, M. E., Green, D. A.
10.1101/2022.02.08.22270591 — Posted: 2022-02-09
Cardiovascular Signatures of COVID-19 Predict Mortality and Identify Barrier Stabilizing Therapies
Gustafson, D., Ngai, M., Wu, R., Hou, H., Schoffel, A., Erice, C., Mandla, S., Billia, F., Wilson, M. D., Radisic, M., Fan, E., Trahtemberg, U., Baker, A., McIntosh, C., Fan, C.-P. S., dos Santos, C. C., Kain, K. C., Hanneman, K., Thavendiranathan, P., Fish, J. E., Howe, K. L.
10.1101/2022.02.08.22270636 — Posted: 2022-02-09
Monitoring SARS-CoV-2 in wastewater during New York City's second wave of COVID-19: Sewershed-level trends and relationships to publicly available clinical testing data
Hoar, C., Chauvin, F., Clare, A., McGibbon, H., Castro, E., Patinella, S., Katehis, D., Dennehy, J. J., Trujillo, M., Smyth, D. S., Silverman, A. I.
10.1101/2022.02.08.22270666 — Posted: 2022-02-09
The interaction effect between hemoglobin and hypoxemia on COVID-19 mortality in a sample from Bogota, Colombia: An exploratory study.
Patino-Aldana, A. F., Ruiz Sternberg, A. M., Pinzon-Rondon, A. M., Molano-Gonzalez, N., Rodriguez-Lima, D. R.
10.1101/2022.02.07.22270640 — Posted: 2022-02-09

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).